Empfehlung
5,1
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
Stammdaten
Unternehmen
| Name | Oruka Therapeutics, Inc. |
|---|---|
| Ticker | ORKA |
| CIK | 0000907654 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Oruka Therapeutics, Inc. |
Status
| Zuletzt geprüft | 2026-03-23 02:38:30.933546 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -105,433,000 | 488,617,000 | 471,930,000 | ||
| 2023-12-31 | 10-K | 0 |
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -2,921 | 40.11 | -117,158.68 | -154,0% | |
| 2026-03-16 | Quinlan Paul T | Officer, General Counsel | Open Market Sale | -733 | 41.30 | -30,272.90 | -39,8% | |
| 2026-03-16 | Agarwal Arjun | Officer, Senior Vice President, Finance | Open Market Sale | -395 | 41.30 | -16,313.50 | -21,4% | |
| 2026-03-16 | Agarwal Arjun | Officer, Senior Vice President, Finance | Open Market Sale | -395 | 41.30 | -16,313.50 | -21,4% | |
| 2026-03-16 | Klein Lawrence Otto | Director, Officer, Chief Executive Officer | Open Market Sale | -1,729 | 41.30 | -71,407.70 | -93,9% | |
| 2026-03-16 | Sandler Laura Lee | Officer, Chief Operating Officer | Open Market Sale | -600 | 41.30 | -24,780.00 | -32,6% | |
| 2026-03-16 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -641 | 41.30 | -26,473.30 | -34,8% | |
| 2026-03-16 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -1,177 | 41.94 | -49,358.79 | -64,9% | |
| 2026-03-16 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -2,902 | 41.20 | -119,568.78 | -157,2% | |
| 2026-03-02 | Sandler Laura Lee | Officer, Chief Operating Officer | Open Market Sale | -2,325 | 33.28 | -77,386.00 | -101,7% | |
| 2026-03-02 | Sandler Laura Lee | Officer, Chief Operating Officer | Open Market Sale | -2,675 | 33.81 | -90,435.60 | -118,9% | |
| 2026-02-17 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -6,064 | 32.30 | -195,872.66 | -257,4% | |
| 2026-02-17 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -936 | 32.78 | -30,686.01 | -40,3% | |
| 2026-01-15 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -2,619 | 32.24 | -84,428.70 | -111,0% | |
| 2026-01-15 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -4,381 | 31.56 | -138,275.75 | -181,7% | |
| 2026-01-02 | Sandler Laura Lee | Officer, Chief Operating Officer | Open Market Sale | -3,144 | 29.08 | -91,431.92 | -120,2% | |
| 2026-01-02 | Sandler Laura Lee | Officer, Chief Operating Officer | Open Market Sale | -1,108 | 29.75 | -32,966.99 | -43,3% | |
| 2026-01-02 | Sandler Laura Lee | Officer, Chief Operating Officer | Open Market Sale | -8,748 | 28.17 | -246,396.17 | -323,9% | |
| 2025-12-19 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -1,492 | 30.70 | -45,806.04 | -60,2% | |
| 2025-12-19 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -641 | 28.53 | -18,289.14 | -24,0% | |
| 2025-12-19 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -1,787 | 29.62 | -52,934.51 | -69,6% | |
| 2025-12-19 | Goncalves Joana | Officer, Chief Medical Officer | Open Market Sale | -3,080 | 31.58 | -97,263.32 | -127,8% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.